Wuhan and ePlay Announce Strategic Partnership to Create New Medical Cannabis App
Dr. Anna, in new augmented reality app, helps retail, educate, and inform cannabis customers.
Toronto, Canada -- October 4, 2018 -- InvestorsHub NewsWire -- Wuhan General Group (China), Inc. (OTC:WUHN) is delighted to announce a new exclusive strategic partnership agreement signed today with ePlay Digital Inc. (CSE:EPY) to utilize Mobvovivo's Augmented Reality (AR) platform in education, mobile product information, and e-commerce to support medical cannabis and cannabidiol (CBD) product marketing and sales. The companies will work together to create the Dr. Anna MD app - A Practical Guide to Cannabis.
Wuhan recently announced the appointment of Dr. Anna Morera Leralta, ("Dr. Anna") as the company's chief medical officer (CMO). Dr. Anna is a researcher, thought leader and medical practitioner in the integrative medicine and medical cannabis fields.
"Augmented Reality will help people learn about and easily understand the medical benefits of CBD and related cannabis products directly on their mobile phones," says Dr. Anna Morera Leralta, medical doctor, CMO of Wuhan. "Advancing the community's insight of cannabis and cannabinoids, and ultimately providing society with alternative options and best practices is badly needed."
The Dr. Anna MD app will allow users to operate their iPhone and Android cameras to get further information about cannabis products while driving advertising revenue, sales, and data analytics. Information about safety, efficacy, and effectiveness of cannabis and cannabinoids in pain, symptom management, and other conditions, will be available for products worldwide. Manufacturers and retailers will utilize Dr. Anna MD for training staff, marketing, and as a service offered to their retail and e-commerce customers. Customers and patients will rely on Dr. Anna MD to better understand the benefits, safety, and performance of an exploding number of new products.
"Ultimately, people will get to know Dr. Anna, as she appears in Augmented Reality, as a great and trusted source of information for cannabis and cannabinoids," says Trevor Doerksen, CEO of ePlay Digital. "In situations where packaging and advertising is limited, users will have access to more information from Dr. Anna by simply pointing their iPhone or Android phone at products."
In Canada, California, and other jurisdictions, governments require utilitarian, plain Cannabis packaging and place heavy restrictions on Cannabis advertising. Dr. Anna will help cannabis consumers learn more about products and where to buy them in real time through iPhone and Android smartphones. As a trusted source in an emerging marketplace more information will appear through interactive video and AR when customers point their camera to any product label or advertising at retail or on a website.
The global legal cannabis market is expected to reach USD 146.4 billion by end of 2025. Growing adoption of cannabis in several medical applications such as cancer, mental disorders, chronic pain and others is expected to propel revenue growth. Marketing and advertising budgets will be funneled into approved approaches such as education and technologies that can deliver more information about products to consumers easily.
ePlay Digital Inc. is a mobile game creator and publisher specializing in sports and entertainment augmented reality titles, including their new flagship title Big Shot Basketball. ePlay is operated by an award-winning team of sports, gaming and eSports leaders as well as broadcast and digital technology industry experts, software engineers and athletes who have brought dozens of game titles to market for companies including Time Warner Cable, ESPN, Sony Pictures, AXS TV, Intel, AXN, Fiat, CBS, and others.
About Wuhan General Group (China), Inc.
Wuhan General Group (China), Inc., is a Nevada-based investment company focus in emerging technology and in medical cannabis and cannabidiol (CBD) sectors. Through acquisitions, Wuhan will enter the international 146.4 billion growing cannabis market for the medical applications such as cancer, mental disorders, chronic pain, and others is expected to propel revenue growth in Canada, the United States, and Europe.
For further information please contact:
Publicly traded company (OTC Pink: WUHN)
Telephone: (514) 928-7368
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
Source: Wuhan General Group (China), Inc